QA: Propanc Biopharma Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001517681_2015_Propanc_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001517681, Propanc Biopharma Inc

  xvar xval
0 AssetsCurrent 113,745
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,522,059
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 742,037
9 ResearchAndDevelopmentExpense 8,168
10 remainder_Expenses -37,251
11 remainder_Revenues 0
12 remainder_NetIncome -116,610
13 remainder_ComprehensiveNetIncome -58,274
  yvar yval
0 Assets 113,745
1 Liabilities 1,522,059
2 Expenses 712,954
3 Revenues 0
4 StockholdersEquity -1,408,314
5 NetIncome -829,564
6 ComprehensiveNetIncome -858,701
7 BaseVar 1,261,821
8 EconomicCapitalRatiobeforeLimitedLiability -4.80
9 EconomicCapitalRatio 0.223

Edgar->Model Mapping

Feature Distribution